Aviva Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.14B |
| 2 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$96.9M |
| 3 |
NVIDIA
NVDA
|
+$86.8M |
| 4 |
Microsoft
MSFT
|
+$86.3M |
| 5 |
Coca-Cola
KO
|
+$75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$90.4M |
| 2 |
CRH
CRH
|
+$79.8M |
| 3 |
Moody's
MCO
|
+$63.3M |
| 4 |
Procter & Gamble
PG
|
+$61.9M |
| 5 |
TSMC
TSM
|
+$56.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.72% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.55% |
| 4 | Communication Services | 9.75% |
| 5 | Consumer Discretionary | 9.41% |
No holdings matched the selected filter criteria.
Similar funds
Aviva's Q1 2026 Portfolio in Review
As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.
- Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
- Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
- Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
- Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
- Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
- Aviva opened 50 new positions and closed 66 in Q1 2026.
- Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.
Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.